SORRENTINO, SABATO
 Distribuzione geografica
Continente #
NA - Nord America 849
AS - Asia 526
EU - Europa 389
SA - Sud America 50
AF - Africa 9
OC - Oceania 1
Totale 1.824
Nazione #
US - Stati Uniti d'America 820
SG - Singapore 329
CN - Cina 143
IT - Italia 141
DE - Germania 59
SE - Svezia 41
BR - Brasile 40
GB - Regno Unito 36
NL - Olanda 34
FI - Finlandia 32
CA - Canada 22
HK - Hong Kong 14
FR - Francia 8
PL - Polonia 7
ZA - Sudafrica 7
IQ - Iraq 6
JP - Giappone 6
CZ - Repubblica Ceca 5
IN - India 5
VN - Vietnam 5
ES - Italia 4
RO - Romania 4
AT - Austria 3
BE - Belgio 3
CO - Colombia 3
MX - Messico 3
TR - Turchia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
CH - Svizzera 2
LT - Lituania 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AR - Argentina 1
BB - Barbados 1
BD - Bangladesh 1
BH - Bahrain 1
CL - Cile 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
KZ - Kazakistan 1
MA - Marocco 1
MY - Malesia 1
NR - Nauru 1
PY - Paraguay 1
RS - Serbia 1
RU - Federazione Russa 1
SY - Repubblica araba siriana 1
TL - Timor Orientale 1
UA - Ucraina 1
VE - Venezuela 1
Totale 1.824
Città #
Singapore 211
Chandler 103
Santa Clara 98
Hefei 92
Dallas 55
Milan 50
Ashburn 49
Munich 42
Lawrence 34
Princeton 34
Chicago 24
London 23
Wilmington 20
Helsinki 19
Los Angeles 18
Hong Kong 13
New York 13
Turku 13
Rome 11
Assago 10
Boardman 9
Brooklyn 9
Ottawa 9
São Paulo 9
Amsterdam 8
Atlanta 8
San Francisco 8
Shanghai 8
Des Moines 7
Stockholm 7
Catanzaro 6
Johannesburg 6
Redmond 6
Warsaw 6
Charlotte 5
Hanover 5
Tokyo 5
Madison 4
Montreal 4
Olomouc 4
Augusta 3
Bari 3
Boston 3
Buffalo 3
Erbil 3
Ferrara 3
Guangzhou 3
Ho Chi Minh City 3
Mexico City 3
Portofino 3
Redwood City 3
Tashkent 3
The Dalles 3
Ankara 2
Beijing 2
Bocale 2
Chennai 2
Columbus 2
Cosenza 2
Hasselt 2
Horia 2
Houston 2
Jeddah 2
Manchester 2
Miami 2
Naples 2
Nuremberg 2
Perugia 2
Raleigh 2
San Jose 2
San Nicola Manfredi 2
Seattle 2
Terlizzi 2
Topeka 2
Trento 2
Uberaba 2
Verona 2
Vibo Valentia 2
Washington 2
Addis Ababa 1
Ajman 1
Ambato 1
Ampére 1
Anaheim 1
Annapolis 1
Arapongas 1
Baghdad 1
Barra Mansa 1
Barranquilla 1
Bengaluru 1
Berazategui 1
Berlin 1
Bogotá 1
Bolzano 1
Brasília 1
Bremen 1
Brescia 1
Bridgetown 1
Cabo Frio 1
Calgary 1
Totale 1.177
Nome #
Empagliflozin prevents doxorubicin-induced myocardial dysfunction 61
B-Type Natriuretic Peptide as Biomarker of COVID-19 Disease Severity-A Meta-Analysis 45
Hand Laser Perfusion Imaging to Assess Radial Artery Patency: A Pilot Study. 44
Hindlimb Ischemia Impairs Endothelial Recovery and Increases Neointimal Proliferation in the Carotid Artery. 44
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials 43
Mir-16 Modulates Endothelial Dysfunction After Balloon Injury in a Rat Model of Chronic Peripheral Ischemia. 42
Indirect Comparison of the Efficacy and Safety of Alirocumab and Evolocumab: A Systematic Review and Network Meta-Analysis 41
Down-Regulation of miR-23/27/24 Clusters by TGF-beta 1 Signalling Induces Phenotypic Switching of Vascular Smooth Muscle Cells in vitro and in Response to Vascular Injury in vivo. 40
Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis 39
The Role of Mir-16 on Endothelial Dysfunction in Rat with Atherosclerotic Diet with a Chronic Model of Femoral Artery Occlusion and Carotid Balloon Injury. 38
Flow-Responsive Noncoding RNAs in the Vascular System: Basic Mechanisms for the Clinician 38
Predictors of outcomes in patients with mitral regurgitation undergoing percutaneous valve repair 37
Corrigendum to “miR-125a-5p Modulates Phenotypic Switch of Vascular Smooth Muscle Cells by Targeting ETS-1” (J. Mol. Biol. Jun 16 2017; 429(12):1817–1828) (S002228361730222X) (10.1016/j.jmb.2017.05.008) 36
New Antithrombotic Strategies and Coronary Stent Technologies for Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention 36
Early reduction of left atrial function predicts adverse clinical outcomes in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement 35
Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. 34
MicroRNA-1 Downregulation Increases Connexin 43 Displacement and Induces Ventricular Tachyarrhythmias in Rodent Hypertrophic Hearts. 34
Multichannel Electrocardiograms Obtained by a Smartwatch for the Diagnosis of ST-Segment Changes 34
Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 33
Direct Oral Anticoagulants in Patients With Active Cancer 33
Differences in coagulopathy indices in patients with severe versus non-severe COVID-19: a meta-analysis of 35 studies and 6427 patients 30
Instantaneous wave-Free Ratio (iFR) and Gradient (iFG): new promising adenosine-independent alternative to fractional flow reserve. Preliminary results from the FORECAST Study. 29
The instantaneous wave-Free Ratio (iFR) for evaluation of non culprit lesions in patients with Acute Coronary Syndrome and multivessel disease. 29
Down-regulation of miR-23b induces phenotypic switching of vascular smooth muscle cells in vitro and in vivo 29
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk Patients for the Treatment of Severe Aortic Stenosis 28
The duration of balloon inflation affects the luminal diameter of coronary segments after Bioresorbable Vascular Scaffolds deployment 27
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor. 27
Non-invasive myocardial work is reduced during transient acute coronary occlusion 27
Acute expansion of nitinol-based self-expandable device in patients undergoing transfemoral aortic valve implantation 26
[Debate on dual pathway inhibition: Antiplatelet and anticoagulant therapies in patients undergoing percutaneous coronary intervention at high risk for recurrent ischemic events. Focus on anticoagulation-based strategies] 25
Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices 24
Non-Invasive Myocardial Work in Patients with Severe Aortic Stenosis 24
Reliability of Instantaneous Wave-Free Ratio (iFR) for the Evaluation of Left Main Coronary Artery Lesions 23
Prediction of Significant Coronary Artery Disease Through Advanced Echocardiography: Role of Non-invasive Myocardial Work 23
The Effects of Statins, Ezetimibe, PCSK9-Inhibitors, Inclisiran, and Icosapent Ethyl on Platelet Function 22
Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve implantation in patients without indications for chronic oral anticoagulation: a systematic review and network meta-analysis of randomized controlled trials 22
Risk of Bleeding in Elderly Patients Undergoing Transcatheter Aortic Valve Implantation or Surgical Aortic Valve Replacement 22
Cellular and Molecular Mechanisms Underlying Tricuspid Valve Development and Disease 22
Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions 21
Stent Thrombosis After Percutaneous Coronary Intervention: From Bare-Metal to the Last Generation of Drug-Eluting Stents 21
Standard Versus Ultrasound-Guided Cannulation of the Femoral Artery in Patients Undergoing Invasive Procedures: A Meta-Analysis of Randomized Controlled Trials 20
Single Versus Dual Antiplatelet Therapy Following TAVR: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 19
Simultaneous Radial and Ipsilateral Ulnar Artery Compression versus Isolated Radial Artery Compression after Conventional Radial Access for Coronary Angiography and/or Intervention: A Systematic Review and Meta-Analysis 19
Small‐vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus‐eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post‐Approval studies 17
Stent Thrombosis and Restenosis with Contemporary Drug-Eluting Stents: Predictors and Current Evidence 17
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation 17
Bleeding Risk, Dual Antiplatelet Therapy Cessation, and Adverse Events After Percutaneous Coronary Intervention 17
Incidence, Predictors, and Prognostic Impact of Neurologic Events After TAVR According to VARC-3 Criteria 17
The prevalence, predictors and outcomes of guideline‐directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry 16
Calculated Serum Osmolality, Acute Kidney Injury, and Relationship to Mortality after Percutaneous Coronary Intervention 16
Incidence and outcomes of transient new-onset atrial fibrillation complicating acute coronary syndromes: results from a systematic review and meta-analysis 16
Effect of valve design and anticoagulation strategy on 30‐day clinical outcomes in transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 16
Acute Kidney Injury After Transcatheter Aortic Valve Replacement Mediates the Effect of Chronic Kidney Disease 16
The link between anemia and adverse outcomes in patients with acute coronary syndrome 15
Sex‐Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient‐Level Pooled Analysis From 4 Postapproval Studies 15
Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease 15
Cerebral Embolic Protection During TAVR 14
Impact of percutaneous closure device type on vascular and bleeding complications after TAVR: A post hoc analysis from the BRAVO‐3 randomized trial 14
Effects of Body Mass Index on Clinical Outcomes in Female Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents 14
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk 14
The importance of the Heart Team evaluation before transcatheter aortic valve replacement: Results from the BRAVO‐3 trial 14
null 14
Impact of Baseline Atrial Fibrillation on Outcomes Among Women Who Underwent Contemporary Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 13
Edwards SAPIEN Versus Medtronic Aortic Bioprosthesis in Women Undergoing Transcatheter Aortic Valve Implantation (from the Win-TAVI Registry) 13
Safety and efficacy of nonvitamin K antagonist oral anticoagulants during catheter ablation of atrial fibrillation: A systematic review and meta‐analysis 13
Early hemodynamic impact of SGLT2 inhibitors in overweight cardiometabolic heart failure: beyond fluid offloading to vascular adaptation– a preliminary report 13
Rationale for Early Administration of PCSK9 Inhibitors in Acute Coronary Syndrome 13
Bioprosthetic leaflet thrombosis and reduced leaflet motion after transcatheter aortic valve replacement: A systematic review and meta-analysis 13
Common Calcified Femoral Artery Rupture After Intravascular Lithotripsy for TAVR Implantation 12
Paravalvular Leak 12
Temporal trends, determinants, and impact of high-intensity statin prescriptions after percutaneous coronary intervention 12
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry) 12
Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age 11
White blood cell count and clinical outcomes after left main coronary artery revascularization: insights from the EXCEL trial 11
Mechanical heart valves between myths and new evidence: a systematic review and meta-analysis 11
Limitations of Current Risk Scoring in Real World Populations: The Importance of External Validation 11
Impact of renal function in high bleeding risk patients undergoing percutaneous coronary intervention: a patient-level stratified analysis from four post-approval studies 11
Long-term Safety and Efficacy of New-Generation Drug-Eluting Stents in Women With Acute Myocardial Infarction 11
Assessing and minimizing the risk of percutaneous coronary intervention in patients with chronic kidney disease 11
Influence of Baseline Anemia on Dual Antiplatelet Therapy Cessation and Risk of Adverse Events After Percutaneous Coronary Intervention 11
Residual Inflammatory Risk in Patients With Low LDL Cholesterol Levels Undergoing Percutaneous Coronary Intervention 11
Temporal Trends in Statin Prescriptions and Residual Cholesterol Risk in Patients With Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention 11
Determinants of Significant Out-Of-Hospital Bleeding in Patients Undergoing Percutaneous Coronary Intervention 11
Causes, Timing, and Impact of Dual Antiplatelet Therapy Interruption for Surgery (from the Patterns of Non-adherence to Anti-platelet Regimens In Stented Patients Registry) 11
Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study 10
Clinical manifestations and outcomes of coronavirus disease‐19 in heart transplant recipients: a multicentre case series with a systematic review and meta‐analysis 10
Incidence, predictors and impact of stroke on mortality among patients with acute coronary syndromes following percutaneous coronary intervention—Results from the PROMETHEUS registry 10
Impact of pre‐existing or new‐onset atrial fibrillation on 30‐day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial 10
Feasibility of measuring patient-reported health status at time of percutaneous coronary intervention: Results from a single-center quality-improvement initiative 9
The Telecardiology Revolution: From Emergency Management to Daily Clinical Practice 9
Incidence, predictors and clinical impact of permanent pacemaker insertion in women following transcatheter aortic valve implantation: Insights from a prospective multinational registry 9
Stent Thrombosis After Percutaneous Coronary Intervention 8
Impact of coronary artery disease and percutaneous coronary intervention in women undergoing transcatheter aortic valve replacement: From the WIN‐TAVI registry 8
Reduction of hospitalisations and increased mortality for acute coronary syndromes during covid-19 era: Not all countries are equal 6
Use of prasugrel vs clopidogrel and outcomes in patients with and without diabetes mellitus presenting with acute coronary syndrome undergoing percutaneous coronary intervention 4
Residual inflammatory risk and the impact on clinical outcomes in patients after percutaneous coronary interventions 2
Geographical Variations in Patterns of DAPT Cessation and Two-Year PCI Outcomes: Insights from the PARIS Registry 2
Totale 1.995
Categoria #
all - tutte 26.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202153 0 0 12 0 10 4 5 6 5 3 2 6
2021/2022117 0 0 3 29 10 4 0 27 11 13 17 3
2022/2023352 74 12 40 12 45 28 3 26 52 21 30 9
2023/2024235 28 22 12 12 3 42 0 13 64 5 20 14
2024/2025835 97 35 34 22 61 137 43 16 79 15 118 178
2025/2026348 100 240 8 0 0 0 0 0 0 0 0 0
Totale 1.995